MYO News and Press, Myomo Inc. From 07/27/21

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that the Healthcare Quality Asso...

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that management will participate...

Myomo (MYO) has announced that its stock will be added to the Russell Microcap® Index at the opening of trading today. "This is an exciting milestone for Myomo to further raise awareness of our company within the global investment community and further our work to bring an improved quali...

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that its stock will be added to ...

Presentation Times and Weblinks Released for Approximately 70 Presenting Companies Wednesday and Thursday, June 23-24, 2021 NEW YORK, NY / ACCESSWIRE / June 22, 2021 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day Summer Virtual Small...

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul R. Gudonis, Chief Exec...

Inventor, Researcher, Medical Device Manufacturer Executive Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorder...

Gainers: Trxade (MEDS) +100%, Reneo Pharmaceuticals (RPHM) +13%, ProPhase Labs (PRPH) +18%, Verona Pharma (VRNA) +13%, Myomo (MYO) +8%.Losers: Aethlon Medical (AEMD) -28%, Ocugen (OCGN) -23%, Ra Medical Systems (RMED) -16%, SCWo...

Myomo's management has a history of diluting shareholders. The firm is still burning cash. Therefore, I will pass on this stock. Myomo claims it will become cash flow positive in Q4 by increasing direct billing, but it has already done that in the past few years without getting to bre...

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today provided an update regarding its applicati...